BioCorRx Inc. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
BioCorRx Inc. (BICX) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2023-03-31
- BioCorRx Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $0.00.
- BioCorRx Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2021 was $0.00.
- BioCorRx Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2020 was $0.00.
- BioCorRx Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
| 2018-12-31 | $551.84K 10-K · filed 2019-04-16 |
| 2017-12-31 | $780.02K 10-K · filed 2019-04-16 |
| 2016-12-31 | $642.51K 10-K · filed 2018-04-05 |
| 2015-12-31 | $570.63K 10-K · filed 2017-04-13 |
| 2014-12-31 | $752.84K 10-K · filed 2016-04-14 |
| 2013-12-31 | $1.19M 10-K · filed 2015-03-31 |
| 2012-12-31 | $365.71K 10-K · filed 2014-04-14 |